A Multicenter, Open-label, Phase 2 Basket Study of MK-7684A, a Coformation of Vibostolimab (MK-7684) with Pembrolizumab (MK-3475), With or Without Other Anticancer Therapies in Participants with Selected Solid Tumors
- Zaid, Tarrik (PI)
- Alaniz, Anne (Key Personnel)
- Singh, Monisha (Key Personnel)
- Suri, Anuj (Key Personnel)
Project: Clinical Trial